Preprint
via OpenAlex
Cellular Senescence and SASP in Bladder Ageing: Mechanisms and Emerging Interventions
DOAJ (DOAJ: Directory of Open Access Journals) · 2026
Cellular senescence
Altered intercellular communication
Chronic inflammation
Senolytics
Human
Preclinical / animal
Review
Abstract
Junfeng Yan,1,* Danjie Zhang,2,* Fan Zhao31Department of Urology, Zhejiang Hospital, Hangzhou, Zhejiang, People’s Republic of China; 2The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People’s Republic of China; 3Department of Urology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, People’s Republic of China*These authors contributed equally to this workCorrespondence: Fan Zhao, Email [email protected]: Bladder dysfunction is a prevalent age-related condition that severely impairs quality of life in older adults and commonly manifests as lower urinary tract symptoms (LUTS), including frequency, urgency, incontinence, and nocturia. Cellular senescence(definition), characterized by irreversible cell-cycle arrest accompanied by persistent metabolic activity, is increasingly recognized as a contributor to age-associated tissue degeneration. Senescent cells secrete a diverse array of inflammatory cytokines, chemokines, growth factors, and matrix-remodeling enzymes, collectively termed the senescence-associated secretory phenotype (SASP), which can disrupt tissue homeostasis through autocrine and paracrine signaling. Yet the bladder remains relatively understudied, and evidence linking cellular senescence and SASP to bladder dysfunction is fragmented and predominantly preclinical. Key uncertainties concern cell-specific SASP sources, causality, bladder-specific biomarkers, and validation in human tissues. To address this gap, this review critically integrates and evaluates bladder-specific evidence across ageing-related dysfunction, radiation-induced bladder injury, chemotherapy-induced cystitis, and interstitial cystitis/bladder pain syndrome, while distinguishing direct mechanistic evidence from indirect or pathway-based associations. We further synthesize emerging senescence-targeted strategies, including senolytics(definition) and senomorphics, and highlight the context- and cell-dependent nature of therapeutic responses. By defining the current strength and limitations of the evidence and identifying key translational priorities, this review provides an integrated framework for understanding how cellular senescence and SASP may contribute to bladder dysfunction and for guiding the development of mechanism-based, biomarker-informed interventions.Keywords: cellular senescence, senescence-associated secretory phenotype, bladder ageing, lower urinary tract symptoms, senolytics, radiation- and chemotherapy-induced cystitis
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- Canonical
- link ↗
- Fetched
- 2026-10-05 MST
Cite this
APA
J, Y., D, Z., & F, Z. (2026). Cellular Senescence and SASP in Bladder Ageing: Mechanisms and Emerging Interventions. <em>DOAJ (DOAJ: Directory of Open Access Journals)</em>. https://openalex.org/W7213716870
Vancouver
J Y, D Z, F Z. Cellular Senescence and SASP in Bladder Ageing: Mechanisms and Emerging Interventions. DOAJ (DOAJ: Directory of Open Access Journals). 2026.
BibTeX
@unpublished{yan2026Cellul,
title = {Cellular Senescence and SASP in Bladder Ageing: Mechanisms and Emerging Interventions},
author = {Yan J and Zhang D and Zhao F},
journal = {DOAJ (DOAJ: Directory of Open Access Journals)},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International Journal of General Medicine 2026
Open access · CC-BY
Cellular Senescence and SASP in Bladder Ageing: Mechanisms and Emerging Interventions
International journal of general medicine 2026
Open access · OA
Cellular Senescence and SASP in Bladder Ageing: Mechanisms and Emerging Interventions.
Ageing research reviews 2026
Citation only
A compendium of circulating biomarkers of senescence in humans: Insights on mechanistic impact across health domains and modulation by therapeutic interventions.
British Journal of Clinical Pharmacology 2026
Open access · OA
Therapeutic reversal of cellular senescence: A systematic review of senolytics, senomorphics and anti‐ageing therapies in human clinical trials
Preprints.org 2025
Preprint · CC-BY
Metabolically Active but Dysfunctional: The Role of Senescence and SASP in Metabolic Diseases
International Journal of Molecular Medicine 2025
Open access · CC-BY